Remove 2030 Remove Packaging Remove Vaccines
article thumbnail

17th edition of CPHI & PMEC India inaugurated at India Expo Centre, Noida

Express Pharma

With the Indian pharma market projected to grow to $ 130 billion by 2030 and $ 450 billion by 2047, the event highlighted the industry’s vital role in shaping global healthcare. Projections indicate exports will soar to $130 billion by 2030 and $450 billion by 2047. With exports nearing $27.84

Packaging 105
article thumbnail

Pharma supply chain: From fragile to agile

Express Pharma

The Indian pharma industry is on a solid growth trajectory, surging from $40 billion in 2021 to an estimated $130 billion in 2030, with a steady double-digit CAGR for the next 10 years. It meets 50 per cent of the global demand for various vaccines, 40 per cent of the generic demand in the US, and 25 per cent of all medicine in the UK.

Packaging 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Could virtual reality become an essential tool for healthcare education?

pharmaphorum

Practical examples of this include healthcare professionals using VR to learn various medical procedures or for the technology to be used to teach broader society about public health issues, such as the importance of vaccination. When both ‘treatments’ were combined, the vaccination intention increased even further. The more you know.

Vaccines 145
article thumbnail

16th edition of CPHI & PMEC India Expo to be held from November 28-30, 2023, at India Expo Centre, Greater Noida

Express Pharma

Fette Compacting Machinery India, Ace Technologies & Packaging Systems, DPB Antibiotics, Lee Pharma, Omniscient Health, hcare, Venkata Narayana Active Ingredients, Unilab Chemicals and Pharmaceuticals, and many others. A vaccine manufacturing powerhouse, India leads by supplying over 60 per cent of global vaccine demand.

Packaging 105
article thumbnail

Greening India’s industrial horizon: Navigating climate resilience in pharma and beyond

Express Pharma

It is already a massive $50 billion market and is projected to grow to $130 billion by 2030. India makes 60 per cent of the world’s vaccines and 20 per cent of the world’s generic drugs. India’s pharmaceutical industry is a global powerhouse. The second chink is its climate and environmental footprint.

article thumbnail

Procuring HIV/AIDS medicines from African producers

Quality Matters

Given this dependence on foreign manufacturers, the African Union made regional production a central pillar of its New Public Health Order, and partnerships that support African-produced medicines, vaccines, and other medical products, are central to their efforts. But PEPFAR is looking to change how it does business.

article thumbnail

Budget expectation: Bring GST rate on APIs at par with the formulations

Express Pharma

Initiatives such as Ayushmaan Bharat Digital Mission (“ADBDM”), CoWIN (a digital vaccine delivery platform), health registry, and telemedicine, highlight the government’s strong emphasis on digitisation of health in India. million nurses/midwives in the total stock by 2030. A recent WHO report estimated a shortage of about 1.8